EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation

Jilei Li iD, Wenchao Dan iD, Chenchen Zhang, Nian Liu, Yichong Wang iD, Jixiang Liu, Shengsheng Zhang

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s436359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Jilei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China. Hauptthemen laut MEDLINE: Berberine, Toll-Like Receptor 4, Hypoxia-Inducible Factor 1, alpha Subunit, NF-kappa B. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineToll-Like Receptor 4Hypoxia-Inducible Factor 1, alpha SubunitNF-kappa BColitis, UlcerativeComputational BiologyAnimalsMiceHumansMolecular Docking SimulationLipopolysaccharidesMaleDextran SulfateMice, Inbred C57BLDisease Models, AnimalNetwork Pharmacology

Stichwörter der Autor:innen

TLR4/NF-κB/HIF-1αberberineexperimental validationinhibitormolecular dockingnetwork pharmacologyulcerative colitis

Substanzen

BerberineToll-Like Receptor 4Hypoxia-Inducible Factor 1, alpha SubunitNF-kappa BTLR4 protein, humanLipopolysaccharidesHIF1A protein, humanDextran SulfateTlr4 protein, mouseHif1a protein, mouse

Autor:innen und Institutionen

  • Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China.
  • Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China.
  • Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.

ORCID-Profile: Jilei Li, Wenchao Dan, Yichong Wang

Zitieren

APA

Li, J., Dan, W., Zhang, C., Liu, N., Wang, Y., Liu, J., & Zhang, S. (2024). Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s436359

Vancouver

Li J, Dan W, Zhang C, Liu N, Wang Y, Liu J, et al. Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s436359

BibTeX
@article{Li2024,
  author = {Li, Jilei and Dan, Wenchao and Zhang, Chenchen and Liu, Nian and Wang, Yichong and Liu, Jixiang and Zhang, Shengsheng},
  title = {Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s436359}
}
Kostenlos starten →